These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7790717)

  • 61. PROTEOLYTIC ENZYMES FOR FOOT PROBLEMS IN A STATE INSTITUTION: A PRELIMINARY REPORT.
    KATZ IA; TILLMAN P
    J Am Podiatry Assoc; 1965 Apr; 55():285-6. PubMed ID: 14283616
    [No Abstract]   [Full Text] [Related]  

  • 62. [The drug therapy of chronic venous insufficiency (a trial of the clinical use of the preparation Detralex)].
    Iablokov EG; Bogachev VIu; Domoradskaia AI
    Ter Arkh; 1996; 68(10):80-1. PubMed ID: 9026954
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Proceedings of the XII World Congress of the International Union of Phlebology--parallel session entitled medical and socioeconomic impact of venolymphatic disease: benefit of daflon 500 mg. London, 1995.
    Angiology; 1997 Jan; 48(1):21-98. PubMed ID: 9012311
    [No Abstract]   [Full Text] [Related]  

  • 64. Muscle cramps in postparalytic poliomyelitis treated with hesperidin-ascorbic acid.
    BOINES GJ; HOROSCHAK S
    Int Rec Med; 1960 Jan; 173():31-4. PubMed ID: 13802218
    [No Abstract]   [Full Text] [Related]  

  • 65. Studies on the inhibition of proteolytic enzymes by serum. III. Physiological aspects of variations in proteolytic inhibition. The concurrence of changes in fibrinogen concentration with changes in trypsin inhibition.
    SHULMAN NR
    J Exp Med; 1952 Jun; 95(6):605-18. PubMed ID: 14946323
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structural changes in the activation of chymotrypsinogen and trypsinogen; effect of urea on chymotrypsinogen and delta-chymotrypsin.
    DREYER WJ; NEURATH H; RUPLEY JA
    Arch Biochem Biophys; 1956 Nov; 65(1):243-59. PubMed ID: 13373422
    [No Abstract]   [Full Text] [Related]  

  • 67. [Action of hurain on synthetic substrates of trypsin and chymotrypsin].
    De Seidl DS; Jaffe WG
    Acta Cient Venez; 1965; 16(4):132-6. PubMed ID: 5862788
    [No Abstract]   [Full Text] [Related]  

  • 68. [Electrotherapy in circulatory disorders of the legs].
    Guillemin R; Commandre F; Bonelli AJ
    Electrodiagn Ther; 1977; 14(1):5-8. PubMed ID: 301466
    [No Abstract]   [Full Text] [Related]  

  • 69. [On the mechanism of the anti-edema effect of parenteral crystalline proteases].
    VEREMEENKO KN
    Vopr Med Khim; 1962; 8():525-31. PubMed ID: 13996746
    [No Abstract]   [Full Text] [Related]  

  • 70. [Drugs for veno-lymphatic insufficiency].
    Priollet P; Boisseau MR
    Rev Prat; 2000 Jun; 50(11):1195-8. PubMed ID: 11008499
    [TBL] [Abstract][Full Text] [Related]  

  • 71. THE EFFECT OF PROTEOLYTIC ENZYMES ON SYNTHETIC POLYPEPTIDES.
    SIMONS ER; BLOUT ER
    Biochim Biophys Acta; 1964 Oct; 92():197-9. PubMed ID: 14243781
    [No Abstract]   [Full Text] [Related]  

  • 72. [Not Available].
    Suter PM
    Ther Umsch; 2016 Nov; 73(11):673-678. PubMed ID: 28276270
    [No Abstract]   [Full Text] [Related]  

  • 73. Peptides combined with 14C-diisopropyl phosphoryl following degradation of 14C-DIP-trypsin with alpha-chymotrypsin.
    DIXON GH; GO S; NEURATH H
    Biochim Biophys Acta; 1956 Jan; 19(1):193-5. PubMed ID: 13304098
    [No Abstract]   [Full Text] [Related]  

  • 74. [PROTEOLYTIC ENZYMES IN THE MEDICAL TREATMENT OF PARODONTOPATHIES].
    BENINI A
    Riv Ital Stomatol; 1965 Feb; 20():200-10. PubMed ID: 14289595
    [No Abstract]   [Full Text] [Related]  

  • 75. [Determination of the activity of trypsin, chymotrypsin and elastase in a mixture of proteolytic enzymes].
    AMATI A; CASTELLI B
    Farmaco Prat; 1959 Feb; 14(2):109-19. PubMed ID: 13630280
    [No Abstract]   [Full Text] [Related]  

  • 76. STUDIES ON THE PROTEOLYTIC ENZYME PRODUCED BY DERMATOPHYTES.
    KOTRAJARAS R
    J Invest Dermatol; 1965 Jan; 44():1-5. PubMed ID: 14264277
    [No Abstract]   [Full Text] [Related]  

  • 77. Hesperidin Alleviates Oxidative Stress and Upregulates the Multidrug Resistance Protein 2 in Isoniazid and Rifampicin-Induced Liver Injury in Rats.
    Zhang G; Zhu J; Zhou Y; Wei Y; Xi L; Qin H; Rao Z; Han M; Ma Y; Wu X
    J Biochem Mol Toxicol; 2016 Jul; 30(7):342-9. PubMed ID: 27017938
    [No Abstract]   [Full Text] [Related]  

  • 78. The action of trypsin and chymotrypsin on the sea urchin egg.
    HAGSTROM B; HAGSTROM BRITT
    Exp Cell Res; 1954 May; 6(2):532-4. PubMed ID: 13173509
    [No Abstract]   [Full Text] [Related]  

  • 79. [Leg disorders--disorders of blood supply. The effect of Essaven ultra in chronic venous insufficiency].
    Hirsch J
    Fortschr Med; 1982 Mar; 100(10):436-8. PubMed ID: 7068078
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Studies on the inhibition of proteolytic enzymes by serum. I. The mechanism of the inhibition of trypsin, plasmin, and chymotrypsin by serum using fibrin tagged with I131 as a substrate.
    SHULMAN NR
    J Exp Med; 1952 Jun; 95(6):571-91. PubMed ID: 14946321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.